At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Korean Red Ginsengdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Korean Red Ginseng as Adjuvant Treatment for the Residual Symptoms of Depression
In Brief
A clinical study evaluating Korean Red Ginseng for Major Depressive Disorder. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether Korean Red Ginseng are effective in the treatment of the residual symptoms of depression as an adjuvant treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesSouth Korea
CollaboratorsThe Korean Society of Ginseng
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
First PostedDec 2011
Primary CompletionJul 2012
Study CompletionDec 2012
TodayJul 2026
First PostedDec 21, 2011
Enrollment StartAug 1, 2011
Primary CompletionJul 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 14.5 years ago
Interventions
Korean Red Ginsengdietary
100% of the past psychiatric medication dose will be maintained during 8 week study period. Korean Red ginseng will be started with 2g/day and then maintained using flexible dosing of 2-3g/day during the study period.